Select Publications
Journal articles
, 2026, 'Real-world insights in the use of temozolomide for aggressive pituitary tumours remind us what we still don’t know', Pituitary, 29, http://dx.doi.org/10.1007/s11102-026-01701-w
, 2026, 'Aggressive pituitary neuroendocrine tumors display a distinct immune microenvironment', The Journal of Clinical Endocrinology & Metabolism, pp. dgag306, http://dx.doi.org/10.1210/clinem/dgag306
, 2026, 'Pituitary stalk biopsy – A systematic review of the safety and efficacy of stalk lesion biopsy', Pituitary, 29, http://dx.doi.org/10.1007/s11102-026-01679-5
, 2026, 'Surgery for prolactinoma', Best Practice and Research Clinical Endocrinology and Metabolism, 40, http://dx.doi.org/10.1016/j.beem.2026.102083
, 2026, 'Patient perceptions of pituitary incidentaloma diagnosis and follow-up: a Pituitary Society international patient survey', Pituitary, 29, http://dx.doi.org/10.1007/s11102-025-01614-0
, 2025, 'Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study', Lancet Diabetes and Endocrinology, 13, pp. 1030 - 1040, http://dx.doi.org/10.1016/S2213-8587(25)00249-9
, 2025, 'Pituitary incidentaloma: a Pituitary Society international consensus guideline statement', Nature Reviews Endocrinology, 21, pp. 638 - 655, http://dx.doi.org/10.1038/s41574-025-01134-8
, 2025, 'The landscape of germline variants in breast and colorectal cancer susceptibility genes in patients with pituitary tumours', Journal of Neuro Oncology, 175, pp. 379 - 388, http://dx.doi.org/10.1007/s11060-025-05140-8
, 2025, 'Aggressive pituitary tumours and pituitary carcinomas: molecular insights guiding management and the role of precision oncology', Molecular and Cellular Endocrinology, 607, http://dx.doi.org/10.1016/j.mce.2025.112598
, 2025, 'A core outcome set for pituitary surgery research: an international delphi consensus study', Pituitary, 28, http://dx.doi.org/10.1007/s11102-025-01553-w
, 2025, 'Assessing the clinical application of the PANOMEN 3 classification in a large cohort of pituitary tumors', European Journal of Endocrinology, 193, pp. 56 - 64, http://dx.doi.org/10.1093/ejendo/lvaf122
, 2025, 'Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas', European Journal of Endocrinology, 192, pp. R45 - R78, http://dx.doi.org/10.1093/ejendo/lvaf100
, 2025, 'FGFR1 variation in the divergent settings of congenital hypopituitarism and pituitary tumours', Pituitary, 28, http://dx.doi.org/10.1007/s11102-025-01498-0
, 2025, 'Frailty and pituitary surgery: a systematic review', Pituitary, 28, http://dx.doi.org/10.1007/s11102-025-01507-2
, 2025, 'Identifying research priorities for pituitary adenoma surgery: an international Delphi consensus statement', Pituitary, 28, http://dx.doi.org/10.1007/s11102-025-01502-7
, 2025, 'Delphi panel consensus on recommendations for thromboprophylaxis of venous thromboembolism in endogenous Cushing's syndrome: a position statement', European Journal of Endocrinology, 192, pp. R17 - R27, http://dx.doi.org/10.1093/ejendo/lvaf017
, 2025, 'Approach to the Patient With Suspected Hypotonic Polyuria', Journal of Clinical Endocrinology and Metabolism, 110, pp. e506 - e514, http://dx.doi.org/10.1210/clinem/dgae565
, 2025, 'Inflammation of adenohypophysis is commonly associated with headache in surgically managed Rathke’s cleft cysts', Pituitary, 28, http://dx.doi.org/10.1007/s11102-024-01486-w
, 2024, 'Quality of life in non-functioning pituitary adenoma: A systematic review', Neurosurgical Review, 47, http://dx.doi.org/10.1007/s10143-024-03126-0
, 2024, 'Approach to the Patient: New Era Emerges for Craniopharyngioma Management', Journal of Clinical Endocrinology and Metabolism, 109, pp. 2986 - 2996, http://dx.doi.org/10.1210/clinem/dgae503
, 2024, 'Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus', Clinical Endocrinology, 101, pp. 443 - 445, http://dx.doi.org/10.1111/cen.14819
, 2024, 'Increased Prevalence of Germline Pathogenic CHEK2 Variants in Individuals With Pituitary Adenomas', Journal of Clinical Endocrinology and Metabolism, 109, pp. 2720 - 2728, http://dx.doi.org/10.1210/clinem/dgae268
, 2024, 'Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2', Pituitary, 27, pp. 248 - 258, http://dx.doi.org/10.1007/s11102-024-01385-0
, 2024, 'Headache in Patients with Sellar Disease: Clinicomorphological Predictors of Headache and the Outcome of Endoscopic Transsphenoidal Surgery', Journal of Neurological Surgery Part B Skull Base, 85, pp. 247 - 254, http://dx.doi.org/10.1055/a-2036-0652
, 2024, 'Clinicopathological features of inflamed rathkes cleft cysts: a case series', Endocrine Abstracts, http://dx.doi.org/10.1530/endoabs.99.ep1242
, 2024, 'Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement (Nature Reviews Endocrinology, (2023), 19, 12, (722-740), 10.1038/s41574-023-00886-5)', Nature Reviews Endocrinology, 20, pp. 62, http://dx.doi.org/10.1038/s41574-023-00916-2
, 2023, 'Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement', Nature Reviews Endocrinology, 19, pp. 722 - 740, http://dx.doi.org/10.1038/s41574-023-00886-5
, 2023, 'Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group to Consider Renaming Diabetes Insipidus', Hormone Research in Paediatrics, 96, pp. 423 - 425, http://dx.doi.org/10.1159/000527139
, 2023, 'Predictors of pituitary tumour behaviour: An analysis from long-Term follow-up in 2 tertiary centres', European Journal of Endocrinology, 189, pp. 106 - 114, http://dx.doi.org/10.1093/ejendo/lvad079
, 2023, 'The evolution in pituitary tumour classification: a clinical perspective', Endocrine Oncology, 3, pp. e220079, http://dx.doi.org/10.1530/eo-22-0079
, 2023, 'Initial pathology in aggressive pituitary tumours and carcinomas: 2b or not 2b?-that is the question', European Journal of Endocrinology, 188, pp. C5 - C8, http://dx.doi.org/10.1093/ejendo/lvad042
, 2023, 'Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus', Journal of Clinical Endocrinology and Metabolism, 108, pp. 1 - 3, http://dx.doi.org/10.1210/clinem/dgac547
, 2023, 'Pituitary tumours: molecular and genetic aspects', Journal of Endocrinology, 257, http://dx.doi.org/10.1530/JOE-22-0291
, 2022, 'Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus', The Journal of Clinical Endocrinology & Metabolism, 108, pp. 1 - 3, http://dx.doi.org/10.1210/clinem/dgac547
, 2022, 'Changing the name of diabetes insipidus', Pituitary, 25, pp. 777 - 779, http://dx.doi.org/10.1007/s11102-022-01276-2
, 2022, 'Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours', Pituitary, 25, pp. 997 - 1003, http://dx.doi.org/10.1007/s11102-022-01284-2
, 2022, 'Temozolomide in aggressive pituitary tumours and pituitary carcinomas', Best Practice and Research Clinical Endocrinology and Metabolism, 36, http://dx.doi.org/10.1016/j.beem.2022.101713
, 2022, 'Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus', Endocrine Connections, 11, http://dx.doi.org/10.1530/EC-22-0378
, 2022, 'Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes InsipidusThis article is CC-BY and has been published in the following titles: Archives of Endocrinology and Metabolism, Clinical Endocrinology, Endocrine Connections, Endocrine Journal, European Journal of Endocrinology, Hormone Research in Pediatrics, Pituitary and The Journal of Clinical Endocrinology and Metabolism. The articles are identical except for minor stylistic and spelling differences in keeping with each journal's style. A citation specific to one of the journals may be used when citing this article.', European Journal of Endocrinology, 187, pp. p1 - p3, http://dx.doi.org/10.1530/eje-22-0751
, 2022, 'Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients', European Journal of Endocrinology, 187, pp. 593 - 605, http://dx.doi.org/10.1530/EJE-22-0440
, 2022, 'MEN4, the MEN1 Mimicker: A Case Series of Three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations', Journal of Clinical Endocrinology and Metabolism, 107, pp. 2339 - 2349, http://dx.doi.org/10.1210/clinem/dgac162
, 2022, 'Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement', European Journal of Endocrinology, 186, pp. 35 - 52, http://dx.doi.org/10.1530/EJE-21-1186
, 2022, 'Low but not undetectable early postoperative nadir serum cortisol predicts sustained remission in Cushing’s disease', Endocrine Oncology, 2, pp. 19 - 31, http://dx.doi.org/10.1530/eo-21-0026
, 2022, 'Letter to the Editor From Raven et al: "Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine"', Journal of Clinical Endocrinology and Metabolism, 107, pp. E1767 - E1768, http://dx.doi.org/10.1210/clinem/dgab822
, 2022, 'Female Representation: Australian Diabetes and Endocrinology Societies', Frontiers in Endocrinology, 13, http://dx.doi.org/10.3389/fendo.2022.842909
, 2022, 'Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments', Frontiers in Endocrinology, 13, http://dx.doi.org/10.3389/fendo.2022.868174
, 2022, 'Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas', Pituitary, 25, pp. 64 - 73, http://dx.doi.org/10.1007/s11102-021-01170-3
, 2022, 'Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus', Archives of Endocrinology and Metabolism, 66, pp. 868 - 870, http://dx.doi.org/10.20945/2359-3997000000528
, 2021, 'Consensus on diagnosis and management of Cushing's disease: a guideline update', Lancet Diabetes and Endocrinology, 9, pp. 847 - 875, http://dx.doi.org/10.1016/S2213-8587(21)00235-7
, 2021, 'Childhood-onset prolactinomas—Should earlier surgery be considered?', Clinical Endocrinology, 95, pp. 571 - 573, http://dx.doi.org/10.1111/cen.14477